Technology insight: Liver support systems

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 9, 2005, Pages 398-405

  Millis, J Michael ^a   Losanoff, Julian E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute liver failure; Artificial livers; Artificial organs; Liver support

Indexed keywords

ALBUMIN;

ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; BLOOD TRANSFUSION; CELL TRANSPLANTATION; CLINICAL TRIAL; CROSS CIRCULATION; EXTRACORPOREAL CIRCULATION; FOLLOW UP; HEMADSORPTION; HEMODIALYSIS; HEMOFILTRATION; HEPATIC COMA; HUMAN; LIVER CELL; LIVER FAILURE; LIVER PERFUSION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; XENOGRAFT;

HUMANS; LIVER, ARTIFICIAL; SORPTION DETOXIFICATION;

EID: 27144467132     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0254     Document Type: Review

References (61)

1. van de Kerkhove MP et al. (2004) Clinical application of bioartificial liver support systems. Ann Surg 240: 216-230
2. Punch JD (2004) Bridges to transplantation. Anesthesiol Clin North Am 22: 863-869
3. Millis JM et al. (2002) Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: System modifications and clinical impact. Transplantation 74: 1735-1746
4. Kamohara Y et al. (1998) Artificial liver: Review and Cedars-Sinai experience. J Hepatobiliary Pancreat Surg 5: 273-285
5. George J (2004) Artificial liver support systems. J Assoc Physicians India 52: 719-722
6. Lee C and Tink A (1958) Exchange transfusion in hepatic coma. Report of a case. Med J Austr 1: 40-42
7. Trey MB et al. (1966) Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 274: 473-481
8. Sabin S and Meritt JA (1968) Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann Int Med 68: 1-7
9. Takahashi T et al. (1991) Artificial liver: State of the art. Dig Dis Sci 36: 1327-1340
10. Merrill JP et al. (1950) The use of an artificial kidney II: clinical experience. J Clin Invest 29: 452-438
11. Opolon P (1979) High permeability membrane hemodialysis and hemofiltration in acute hepatic coma. Experimental and clinical results. Artif Organs 3: 354-360
12. Yoshiba M et al. (1993) Development of reliable artificial liver support (ALS) plasma exchange in combination with hemodiafiltration using highperformance membrane. Dig Dis Sci 38: 469-476
13. Khurshid I et al. (2002) Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: Case report and review of the literature. Crit Care Med 30: 2363-2367
14. Ayuub M et al. (2000) Usefulness of exchange transfusion in acute liver failure due to severe P. falciparum malaria. Am J Gastroenterol 95: 802-804
15. Rifai K et al. (2003) Liver replacement therapy. Reliable indications in acute liver failure. Internist 44: 1485-1490
16. Stockmann HB and Ijzermans JN (2002) Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol 14: 195-203
17. Singer AL et al. (2001) Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 234: 418-424
18. Kazama JJ et al. (2003) Successful perioperative blood purification therapy in patients with maintenance hemodialysis therapy who underwent living donor liver transplantation. Clin Nephrol 59: 229-233
19. Borra M et al. (2002) Advanced technology for extracorporeal liver support system devices. Int J Artif Organs 25: 939-949
20. Agarwal R and Farber MO (2002) Is continuous venovenous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile? Clin Nephrol 57: 167-170
21. Bellomo R and Ronco C (2000) Continuous haemofiltration in the intensive care unit. Crit Care 4: 339-345
22. Gimson AE et al. (1982) Earlier charcoal hemoperfusion in fulminant hepatic failure. Lancet 2: 681-683
23. O'Grady JG et al. (1988) Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186-1192
24. Wilkinson AH et al. (1998) Hemodiabsorption in treatment of hepatic failure. J Transplant Coord 8: 43-50
25. Ellis AJ et al. (1999) Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs 22: 27-34
26. Hughes RD (2002) Review of methods to remove protein-bound substances in liver failure. Int J Artif Organs 25: 911-917
27. Hughes RD and Williams R (1993) Use of sorbent columns and haemofiltration in fulminant hepatic failure. Blood Purif 11: 163-169
28. Sen S et al. (2005) Emerging indications for albumin dialysis. Am J Gastroenterol 100: 468-475
29. Felldin M et al. (2003) Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transpl Proc 35: 822-823
30. Mitzner SR et al. (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 6: 277-286
31. Rifai K et al. (2003) Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 39: 984-990
32. de Kerkhove MP et al. (2003) MARS treatment in posthepatectomy liver failure. Liver Int 23 (Suppl 3): 44-51
33. Sauer IM et al. (2004) In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 39: 1408-1414
34. Krebs HA and Henseleit K (1932) Untersuchungen uber die harnstoffbildung im tierkorper. Hoppe-Seyler's Zentralblatt fur Physische Chemie 210: 33-66
35. Otto JJ et al. (1958) The use of a donor liver in experimental animals with elevated blood ammonia. Surgery 43: 301-309
36. Lie TS (1980) Treatment of acute hepatic failure by extracorporeal hemoperfusion over human and baboon liver. In: Artificial liver support, 268-273 (Eds Brunner G and Schmidt FW) Berlin: Springer
37. Wolf CF and Munkelt BE (1975) Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. ASAIO Trans 21: 16-26
38. Argibay PF et al. (2000) Polyacrylonitrile membrane interposition between a xenograft and a patient in fulminant liver failure: The concept of xenohemodiafiltration in clinical practice. ASAIO J 46: 505-510
39. Linke R et al. (1998) Prevention of initial perfusion failure during xenogeneic ex vivo liver perfusion by selectin inhibition. Transplantation 66: 1265-1272
40. Pascher A et al. (1997) Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor. Transplantation 64: 384-391
41. Abouns GM et al. (2001) Successful ex vivo liver perfusion system for hepatic failure pending liver regeneration or liver transplantation. Transplant Proc 33: 1962-1964
42. Chowdhury JR et al. (1998) Human hepatocyte transplantation: Gene therapy and more? Pediatrics 102: 647-648
43. Mito M et al. (1979) Studies on ectopic liver utilizing hepatocyte transplantation into the rat spleen. Transpl Proc 11: 585-591
44. Darby H et al. (1986) Observations on rat spleen reticulum during the development of syngeneic hepatocellular implants. Br J Exp Pathol 67: 329-339
45. Selden AC et al. (1991) Further observations on the survival, proliferation and function of ectopically implanted syngeneic and allogeneic liver cells in rat spleen. Eur J Hepatol Gastroenterol 3: 607-611
46. Selden C and Hodgson H (2004) Cellular therapies for liver replacement. Transpl Immunol 12: 273-288
47. Soriano H (2002) Liver cell transplantation: Human applications in adults and children. In: P Hepatocyte transplantation: proceedings of Falk Symposium 126 (Progress in Gastroenterology and Hepatology Part III) held in Hannover, Germany, October 2-3, 2001, 99-105 (Eds Gupta S et al.) Dordrecht, Boston, London: Kluwer Academic Publishers
48. Strom SC et al. (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63: 559-569
49. Bilir BM et al. (2000) Hepatocyte transplantation in acute liver failure. Liver Transplant 6: 32-40
50. 3A cell metabolism for usage in bioartificial liver support systems. J Hepatol 41: 599-605
51. Gregory PG et al. (2000) In vitro characterization of porcine hepatocyte function. Cell Transplant 9: 1-10
52. Ellis AJ et al. (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24: 1446-1451
53. Samuel D et al. (2002) Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 73: 257-264
54. Rozga J et al. (1994) A bioartificial liver to treat severe acute liver failure. Ann Surg 219: 538-544
55. Watanabe FD et al. (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial. Ann Surg 225: 484-491
56. van de Kerkhove MP et al. (2003) Bridging of a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant 12: 563-568
57. Sauer IM et al. (2003) Extracorporeal liver support based on primary human liver cells and albumin dialysis - treatment of a patient with primary graft nonfunction. J Hepatol 39: 649-653
58. Mazariegos GV et al. (2002) First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant 2: 260-266
59. Demetriou AA et al. (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239: 660-667
60. Kjaergard LL et al. (2003) Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. JAMA 289: 217-222
61. Liu JP et al. (2004) Artificial and bioartificial support systems for liver failure. The Cochrane Database of Systematic Reviews, Issue 1, Art No. CD003628.pub2